10.45%
Expected annualized return
6.39%
Probability of a negative return
–9.12%
99% confidence VaR (1 year)
1. Headline Simulation Results
Based on 10,000 Monte-Carlo simulations over the product's life (up to 24 months):
| Headline metric |
Value |
| Expected annualized return |
10.45% |
| Probability of a negative return |
6.39% |
| 99% confidence VaR (1 year) |
–9.12% |
| Expected holding period |
17.2 months (≈ 1.43 years) |
| Expected total return over the realised holding period |
+14.54% |
| Coupon |
12.00% p.a. — fixed & unconditional, paid quarterly |
| Issuer early-redemption probability (cumulative) |
65.7% |
| Barrier-Event probability (over the life) |
8.6% |
The product converts a fixed, unconditional 12.00% p.a. coupon stream into a defensive
risk/return profile: a modest expected return (10.45% p.a.) delivered with roughly
one-third of the volatility of the underlying shares (4.55% vs 12.76%), in exchange
for giving up essentially all upside participation.
2. How the Product Works (Plain-Language)
- Three underlyings, worst-of: Nestlé, Novartis and Roche. Everything is driven by the worst-performing of the three.
- Coupon is unconditional: the investor receives 12.00% p.a. (USD 30 per USD 1,000 denomination, quarterly) regardless of how the shares move, for as long as the product is alive.
- Conditional capital protection (barrier at 69%): as long as none of the three shares ever trades at or below 69% of its starting level during the ~2-year life, the investor gets the full denomination (100%) back at maturity.
- If the barrier is breached and the worst share finishes below its start: the investor receives the worst-performing share (or its cash equivalent) — i.e. it bears the downside. If the worst share recovers back to/above its start, par is returned.
- Issuer callable: the issuer may redeem early on four quarterly observation dates (months 12, 15, 18, 21). On a call the investor receives par plus the then-current coupon and the product ends. (Because no explicit trigger is published, the call is modelled as being exercised when the worst-of stands at or above its starting level — an ASSUMPTION.)
- Quanto USD: FX exposure to the Swiss franc is neutralised; returns are expressed in USD terms.
Net result: this is a yield-enhancement / reverse-convertible payoff — a bond-like
coupon plus a sold down-and-in “put” on the worst-of basket. Upside is capped; the coupon
is the entire return.
3. Key Statistics (annualized)
| Metric |
Structured product |
Underlying basket (total return, incl. dividends) |
| Expected annualized return |
10.45% |
15.66% |
| Expected annualized volatility |
4.55% |
12.76% |
| Probability of loss |
6.39% |
9.93% |
| 99% confidence VaR (1 year) |
–9.12% |
–10.55% |
Underlying basket proxy = equal-weighted Nestlé / Novartis / Roche; dividend yield ≈ 3.38%.
Underlying price-only expected annualized return ≈ 12.27%. Risk-free rate = 3.79% (1-year average US T-bill).
4. Charts
4.1 Simulation outcomes — product vs underlying
Each dot is one simulation; the dashed line is 1:1. Outcomes sit above the diagonal at low returns (protection/fixed coupon) and grind along a flat ceiling near +24% at high underlying returns (upside is capped). Colour = years held.
4.2 Annualized total-return histograms
Underlying basket (equal-weighted, total return incl. dividends):
Structured product
The underlying distribution is wide and roughly symmetric around its mean; the product distribution is
sharply concentrated near its coupon ceiling, with a small left tail representing barrier-event losses.
4.3 Scenario probabilities (structured product)
4.4 Risk vs return
Consistent with the histogram evidence, the product delivers a materially lower volatility
for a somewhat lower expected return than the underlying.
4.5 Annualized-return box plot
4.6 Holding-period and coupon distributions
Because the product is issuer-callable, it is frequently redeemed before maturity (~66% of paths), so the realised holding period and coupon count vary:
Coupons paid
5. Investment Commentary
Observations from the simulation
- High, unconditional coupon. A flat 12.00% p.a. is paid in every scenario until redemption — the coupon does not depend on the shares and is not contingent on the barrier. This is the dominant driver of the ~10.5% p.a. expected return.
- Downside is tail-driven but capped in scope. The barrier sits at 69%, i.e. ~31% below the start. A Barrier Event occurred in only ~8.6% of paths, and losses beyond that are mild in the average case (99% VaR of –9.12% for the product vs –10.55% for the underlying). The worst simulated outcomes still show meaningful capital loss, as the worst share is delivered below par.
- Strongly lower volatility. Product volatility (4.55%) is about a third of the underlying basket's (12.76%), reflecting the short-put structure: most of the time the product simply returns par plus coupon.
- Early redemption caps the compounding. The average holding period is only ~17.2 months because the issuer calls roughly two-thirds of the paths at or above par. Investors therefore re-invest principal sooner and the realised total return (+14.54%) is lower than a “held-to-maturity” 24% would suggest.
- Upside is fully surrendered. On paths where the basket rallies strongly (up to ~+49% for the underlying within the 1–99% band), the product's annualized return is pinned near its ~12% coupon — the opportunity cost of the capped payoff is clearest precisely when equities do best.
Good points worth mentioning
- Attractive, unconditional yield (12.00% p.a.) relative to the ~3.79% risk-free rate and to the Swiss shares' ~3.4% dividend yield.
- Conditional protection: capital is preserved in the large majority of paths (≈93.6% of simulations are non-negative; barrier breached in only ~8.6%).
- Diversification across three defensive, large-cap Swiss healthcare/consumer names, on a worst-of basis.
- Quanto USD removes CHF currency risk for a USD investor.
- Markedly lower return volatility than holding the shares directly.
Points to weigh
- Upside is capped at the coupon — no participation in a strong basket rally.
- A worst-of structure: the outcome is governed by the single weakest share, and losses (if the barrier is breached) are calculated on that weakest share.
- Issuer callability truncates the coupon stream in the majority of scenarios (~66%).
- Returns (and the barrier) are sensitive to the modelling drift/risk-premium assumption; the fair-value of the embedded short put is a key swing factor.
- Investors retain the issuer/guarantor credit risk.
This material is an analytical evaluation of simulated outcomes only. It is not investment advice, a
recommendation, or a suitability assessment. All figures are model-based and rounded to two decimals.
Note: short holding periods (minimum 12 months in this structure) do not materially distort
the annualized figures, but the expected annualized return should always be read jointly with the expected
holding period (17.2 months) and expected total return (+14.54%).